Systemic sclerosis & Raynaud's

Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States

Semin Arthritis RheumPublished Retrospective cohort study

Authors' conclusion

In this large nationwide sample, the risk of fetal death among women with SSc markedly improved over the past 18 years. The risk for other APOs remained high in SSc deliveries compared to non-SSc deliveries

Study context

Population
Delivery-associated hospitalizations in the United States, National Inpatient Sample 2000–2017
Participants
3,740 SSc delivery hospitalizations
Exposure
SSc deliveries vs matched non-SSc deliveries
  • SScn = 3,740
Outcome
Temporal trends in adverse pregnancy outcomes:
  • Maternal and fetal death
  • Cesarean delivery
  • LOS
  • Preterm delivery
  • Intrauterine growth restriction
  • Hypertensive disorders of pregnancy
Methodological detailsNational Inpatient Sample (NIS) database, 2000 - 2017, each SSc delivery matched to 100 non-SSc deliveries by age, delivery year, and race, multivariable regression with SSc × year interaction term
  • National Inpatient Sample (NIS) database, 2000 - 2017
  • Each SSc delivery matched to 100 non-SSc deliveries by age, delivery year, and race
  • Multivariable regression with SSc × year interaction term

Main finding

As reported in the abstract

Temporal trends in APOs, SSc vs non-SSc · 2000 - 2017

Fetal death in SSc deliveries, 2000 - 2005 (per 1000 delivery-related admissions)

49.0

Fetal death in SSc deliveries, 2012 - 2017 (per 1000 delivery-related admissions)

16.2

Observational data: associations, not effects.

Further findings

SSc associated with an increased risk of all adverse pregnancy outcomes (APOs) vs non-SSc deliveries

Original publication

Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States. Semin Arthritis Rheum. Published 22 August 2023. doi:10.1016/j.semarthrit.2023.152252

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.